2024-517357-27-00招募中4 期
COVID-19 vaccine immunological studies in Finland
Finnish Institute For Health And Welfare1 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2024年10月18日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 4,000
- 试验地点
- 1
- 主要终点
- Proportion of seropositive subjects with an antibody level above the target level in groups of vaccine recipients receiving different vaccine products at 6 months after two doses against the prevailing virus variant
研究概览
简要总结
The main objective of this study is to evaluate immune responses after COVID-19 vaccination with different vaccine formulations
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- •Age 18 years
- •Has received or is planning to receive at least one dose of Covid-19 vaccine in accordance with the Finnish national vaccination programme
- •Is able to understand the given written and oral information
- •Has given written informed consent
排除标准
- 未提供
结局指标
主要结局
Proportion of seropositive subjects with an antibody level above the target level in groups of vaccine recipients receiving different vaccine products at 6 months after two doses against the prevailing virus variant
Proportion of seropositive subjects with an antibody level above the target level in groups of vaccine recipients receiving different vaccine products at 6 months after two doses against the prevailing virus variant
次要结局
- Antibody and neutralising antibody levels and percentages of those above the target: in the group receiving combinations of different vaccine products,in a group of people who received the vaccine at different dose intervals (e.g. 3 weeks, 8 weeks, 12 weeks), in the group receiving different numbers of vaccine doses , in the COVID19-infected group, in different age groups, in groups at risk of COVID-19 and in immunocompromised groups, against different virus variants
- Cell-mediated immune responses
- Response variables regarding immunity studies against other microbes will be developed according to the epidemic situation
研究者
Väestö -osasto, Terveysuhkien torjunta -yksikkö
Scientific
Finnish Institute For Health And Welfare
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
COVID-19 vaccine immunologyMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-004788-29-FIFinnish Institute for Health and Welfare4,000
招募中
1 期
Effect of COV2 vaccine formulation on the ability to generate antibodies against coronavirus2025-523712-37-00Rokote Laboratories Finland Oy20
招募中
4 期
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y)Pertussis2024-510787-23-00Varsinais-Suomen hyvinvointialue138
招募中
4 期
(Pre-BCGvacc) BCG vaccination: can pre-vaccination immune status predict outcome?2024-514428-18-00Leids Universitair Medisch Centrum (LUMC)50
已完成
2 期
Immunogenicity of licensed MF59 adjuvanted Influenza and SARS-CoV-2 vaccine combinations for Older Adults (ISOLDA)2024-514798-23-00Cr2o B.V.120